FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386812648> ?p ?o ?g. }

• W4386812648 endingPage "e20025" @default.
• W4386812648 startingPage "e20025" @default.
• W4386812648 abstract "As society continues to develop, women are more at risk of gonadotoxic substance exposure. Consequently, the incidence of premature ovarian insufficiency (POI) has increased significantly in the past decades. Hormone replacement therapy (HRT) is recommended as the standard treatment to relieve hypoestrogenic symptoms; however, its potential side effects and contraindications have drawn widespread controversy and concern. As such, the Chinese medicine Zishen Yutai Pill (ZSYTP) commonly used for treating miscarriage and menoxenia, is a highly promising alternative drug candidate against POI, however its therapeutic mechanism has not been completely elucidated.To systematically analyze the potential therapeutic targets of ZSYTP on POI, we combined network pharmacology analysis and molecular docking to predict critical target genes, with experimental validation on POI murine models.The active compounds of ZSYTP were collected from three online databases, and the candidate targets were predicted based on the chemical structure. The POI-related targets were obtained from four databases. A PPI network was constructed to find the key target genes between ZSYTP and POI, while GO and KEGG enrichment analyses were employed to study the mechanism of ZSYTP against POI. The binding capability of the key co-targets with active components was examined by molecular docking. We used a cyclophosphamide (CTX)-inducible POI mouse model to verify our predictions by histopathological observation, immunohistochemical staining (caspase-3, TUNEL assay), hormone determination (FSH, AMH) and ribonucleic acid sequencing (RNA Seq). Progynova was also used to study the difference between ZSYTP and HRT.We identified 21 target genes as the hub between ZSYTP and POI. The GO and KEGG analyses revealed that the molecular mechanism of ZSYTP against POI were mainly based on the regulation of gene and protein expression. A variety of signaling pathways may be involved in the treatment of ZSYTP against POI, especially PI3K-AKT, HIF-1 and the AGE-RAGE cascades. Docking simulation showed that G1, C1, SR5, and F1 had relatively lower binding energy. In vivo, ZSYTP significantly reversed CTX-induced ovarian damage in follicle number, hormone level and apoptosis, with an overall improved therapeutic effect compared to Progynova. Results from RNA-Seq revealed that the PI3K-AKT, Hippo, AGE-RAGE, and Rap1 signaling pathways and regulation of inflammation, immune response, and lipid metabolism may mediate the protective effects of ZSYTP against POI, which is different than Progynova's mechanism of action.Collectively, this study indicates that ZSYTP could be a highly promising alternative as a non-HRT-based therapy for POI. Its mechanism involves multiple signaling pathways, alleviating ovarian apoptosis and recovering AMH and FSH level. However, the discrepancy between different research techniques highlight the necessity of further experimental verification from other aspects such as translation and posttranslational modification." @default.
• W4386812648 created "2023-09-18" @default.
• W4386812648 creator A5005216927 @default.
• W4386812648 creator A5008284058 @default.
• W4386812648 creator A5017445578 @default.
• W4386812648 creator A5036083858 @default.
• W4386812648 creator A5036366333 @default.
• W4386812648 date "2023-09-01" @default.
• W4386812648 modified "2023-10-11" @default.
• W4386812648 title "Network analysis and experimental approach to investigate the potential therapeutic mechanism of zishen yutai pills on premature ovarian insufficiency" @default.
• W4386812648 cites W1981922048 @default.
• W4386812648 cites W1993352447 @default.
• W4386812648 cites W1993501543 @default.
• W4386812648 cites W2000836832 @default.
• W4386812648 cites W2006770045 @default.
• W4386812648 cites W2011901078 @default.
• W4386812648 cites W2034172400 @default.
• W4386812648 cites W2062689336 @default.
• W4386812648 cites W2119294728 @default.
• W4386812648 cites W2124679671 @default.
• W4386812648 cites W2127332794 @default.
• W4386812648 cites W2136159364 @default.
• W4386812648 cites W2148028300 @default.
• W4386812648 cites W2158535498 @default.
• W4386812648 cites W2279201083 @default.
• W4386812648 cites W2309700868 @default.
• W4386812648 cites W2488923873 @default.
• W4386812648 cites W2521929712 @default.
• W4386812648 cites W2528283024 @default.
• W4386812648 cites W2530734886 @default.
• W4386812648 cites W2536497136 @default.
• W4386812648 cites W2559134534 @default.
• W4386812648 cites W2565733982 @default.
• W4386812648 cites W2592368601 @default.
• W4386812648 cites W2611425558 @default.
• W4386812648 cites W2735417387 @default.
• W4386812648 cites W2739999456 @default.
• W4386812648 cites W2747858758 @default.
• W4386812648 cites W2767891136 @default.
• W4386812648 cites W2901527454 @default.
• W4386812648 cites W2903167495 @default.
• W4386812648 cites W2905546187 @default.
• W4386812648 cites W2911209755 @default.
• W4386812648 cites W2943922648 @default.
• W4386812648 cites W2946412700 @default.
• W4386812648 cites W2980216096 @default.
• W4386812648 cites W3000239131 @default.
• W4386812648 cites W3004853776 @default.
• W4386812648 cites W3009635487 @default.
• W4386812648 cites W3024601522 @default.
• W4386812648 cites W3025779591 @default.
• W4386812648 cites W3033930536 @default.
• W4386812648 cites W3081510686 @default.
• W4386812648 cites W3106899554 @default.
• W4386812648 cites W3108319220 @default.
• W4386812648 cites W3112984292 @default.
• W4386812648 cites W3120710588 @default.
• W4386812648 cites W3120872113 @default.
• W4386812648 cites W3140912893 @default.
• W4386812648 cites W3161448449 @default.
• W4386812648 cites W3162538759 @default.
• W4386812648 cites W3185008616 @default.
• W4386812648 cites W3189992049 @default.
• W4386812648 cites W3200709530 @default.
• W4386812648 cites W3215182761 @default.
• W4386812648 cites W4210751050 @default.
• W4386812648 cites W4220831425 @default.
• W4386812648 cites W4220892310 @default.
• W4386812648 cites W4253079128 @default.
• W4386812648 cites W4254055538 @default.
• W4386812648 cites W4280543735 @default.
• W4386812648 cites W4313215387 @default.
• W4386812648 cites W4313244994 @default.
• W4386812648 cites W4328001149 @default.
• W4386812648 cites W4362597448 @default.
• W4386812648 doi "https://doi.org/10.1016/j.heliyon.2023.e20025" @default.
• W4386812648 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37809603" @default.
• W4386812648 hasPublicationYear "2023" @default.
• W4386812648 type Work @default.
• W4386812648 citedByCount "0" @default.
• W4386812648 crossrefType "journal-article" @default.
• W4386812648 hasAuthorship W4386812648A5005216927 @default.
• W4386812648 hasAuthorship W4386812648A5008284058 @default.
• W4386812648 hasAuthorship W4386812648A5017445578 @default.
• W4386812648 hasAuthorship W4386812648A5036083858 @default.
• W4386812648 hasAuthorship W4386812648A5036366333 @default.
• W4386812648 hasBestOaLocation W43868126481 @default.
• W4386812648 hasConcept C104317684 @default.
• W4386812648 hasConcept C111472728 @default.
• W4386812648 hasConcept C126322002 @default.
• W4386812648 hasConcept C138885662 @default.
• W4386812648 hasConcept C142724271 @default.
• W4386812648 hasConcept C150194340 @default.
• W4386812648 hasConcept C152724338 @default.
• W4386812648 hasConcept C162317418 @default.
• W4386812648 hasConcept C188947578 @default.
• W4386812648 hasConcept C204787440 @default.
• W4386812648 hasConcept C2777395788 @default.

• next